Kyverna Therapeutics, Inc. (KYTX) Net income 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$161.3MFY2025 · since FY2023: -$60.4M → -$161.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$161.3M | -26.5% |
| FY2024 | -$127.5M | -111.2% |
| FY2023 | -$60.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYTX financial trends
KYTX RevenueKYTX Net marginKYTX Gross profitKYTX Gross marginKYTX Operating incomeKYTX Operating marginKYTX Operating cash flowKYTX Free cash flowKYTX Capital expendituresKYTX Return on equityKYTX Stock buybacksKYTX Dividends paidKYTX Total assetsKYTX Total liabilitiesKYTX Shareholders’ equityKYTX overview →